Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2006 Jun;48(6):644-9.
doi: 10.1097/01.jom.0000204114.01893.3e.

Effective treatment of manganese-induced occupational Parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study

Affiliations
Case Reports

Effective treatment of manganese-induced occupational Parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study

Yue-Ming Jiang et al. J Occup Environ Med. 2006 Jun.

Abstract

Objective: Chronic manganese (Mn) intoxication induces syndromes resembling Parkinson disease. The clinical intervention has largely been unsuccessful. We report a 17-year follow-up study of effective treatment of occupational Mn parkinsonism with sodium para-aminosalicylic acid (PAS).

Methods: The patient, female and aged 50 at the time of treatment, was exposed to airborne Mn for 21 years (1963-1984). The patient had palpitations, hand tremor, lower limb myalgia, hypermyotonia, and a distinct festinating gait. She received 6 g PAS per day through an intravenous drip infusion for 4 days and rested for 3 days as one therapeutic course. Fifteen such courses were carried out between March and June 1987.

Results: At the end of PAS treatment, her symptoms were significantly alleviated, and handwriting recovered to normal. Recent follow-up examination at age 67 years (in 2004) showed a general normal presentation in clinical, neurologic, brain magnetic resonance imaging, and handwriting examinations with a minor yet passable gait.

Conclusions: This case study suggests that PAS appears to be an effective drug for treatment of severe chronic Mn poisoning with a promising prognosis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Handwriting of a manganism patient receiving para-aminosalicylic acid (PAS) therapy. (A) Handwriting at the time of hospital admission before PAS therapy; (B) handwriting at the end of 15-week PAS treatment; and (C) handwriting after 17 years of PAS treatment.
Fig. 2
Fig. 2
T1-weighted magnetic resonance images (MRIs) in the globus pallidus of the patient. (A) Axial T1-weighted MRI, (B) coronal T1-weighted MRI, and (C) sagittal T1-weighted MRI.

References

    1. Olanow CW. Manganese-induced parkinsonism and Parkinson’s disease. Ann N Y Acad Sci. 2004;1012:209–223. - PubMed
    1. Crossgrove J, Zheng W. Manganese tox-icity upon overexposure. NMR Biomed. 2004;17:544–553. - PMC - PubMed
    1. Ono K, Komai K, Yamada M. Myoclonic involuntary movement associated with chronic manganese poisoning. J Neurol Sci. 2002;199:93–96. - PubMed
    1. Pal PK, Samii A, Calne DB. Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology. 1999;20:227–238. - PubMed
    1. Wang JD, Huang CC, Hwang YH, Chiang JR, Lin JM, Chen JS. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br J Ind Med. 1989;46:856–859. - PMC - PubMed

Publication types

MeSH terms

Substances